Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting. [electronic resource]
Producer: 20140721Description: 52-8 p. digitalISSN:- 1473-5687
- Adult
- Antiviral Agents -- adverse effects
- Disease Progression
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Glucose Metabolism Disorders -- prevention & control
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Interferon-alpha -- adverse effects
- Kaplan-Meier Estimate
- Liver Cirrhosis -- prevention & control
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Polyethylene Glycols -- adverse effects
- Proportional Hazards Models
- Prospective Studies
- RNA, Viral -- blood
- Recombinant Proteins -- adverse effects
- Recurrence
- Ribavirin -- adverse effects
- Risk Factors
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.